1. DC-based vaccine loaded with acid-eluted peptides in acute myeloid leukemia: the importance of choosing the best elution method

   • Stéphanie Delluc
   • Léa Tourneur
   • Agnès Buzyn

   Original Article 05 May 2006 Pages: 1 - 12

   

2. Effects of interferon gamma on native human acute myelogenous leukaemia cells

   • Elisabeth Ersvaer
   • Jørn Skavland
   • Øystein Bruserud

   Original Article 13 April 2006 Pages: 13 - 24

   

3. Co-expression of α(1,3)galactosyltransferase and Bacillus thuringiensis PIPLC enhances hyperacute rejection of tumor cells

   • Daniel J. Hellrung
   • Serguei Kisselev
   • Charles J. Link

   Original Article 13 April 2006 Pages: 25 - 34

   

4. Treatment with HPMA copolymer-based doxorubicin conjugate containing human immunoglobulin induces long-lasting systemic anti-tumour immunity in mice

   • Milada Sirova
   • Jiri Strohalm
   • Blanka Rihova

   Original Article 25 April 2006 Pages: 35 - 47

   

5. Tumor-derived CD4⁺CD25⁺ regulatory T cell suppression of dendritic cell function involves TGF-β and IL-10

   • Nicolas Larmonier
   • Marilyn Marron
   • Emmanuel Katsanis

   Original Article 13 April 2006 Pages: 48 - 59

   

6. Complement insufficiency limits efficacy in a xenograft model of hyperacute rejection for cancer therapy

   • James M. G. Larkin
   • Colin D. Porter

   Original Article 20 May 2006 Pages: 60 - 69

   

7. The role of CD4+ T cell help in cancer immunity and the formulation of novel cancer vaccines

   • Deepak P. Assudani
   • Roger B. V. Horton
   • Robert C. Rees

   Symposium Paper 23 March 2006 Pages: 70 - 80

   

8. Tumor escape mechanisms in prostate cancer

   • Ashley M. Miller
   • Pavel Pisa

   Symposium Paper 16 December 2005 Pages: 81 - 87

   

9. Identification of different tumor escape mechanisms in several metastases from a melanoma patient undergoing immunotherapy

   • Rosa Méndez
   • Francisco Ruiz-Cabello
   • Federico Garrido

   Symposium Paper 19 April 2006 Pages: 88 - 94

   

10. Impact of KIR/HLA ligand combinations on immune responses in malignant melanoma

    • Elissaveta Naumova
    • Anastassia Mihaylova
    • Snejina Mihailova

    Symposium Paper 18 March 2006 Pages: 95 - 100

    

11. Lymphocyte activation in response to melanoma: interaction of NK-associated receptors and their ligands

    • Rafael Solana
    • Javier G. Casado
    • Raquel Tarazona

    Symposium Paper 17 February 2006 Pages: 101 - 109

    

12. Recoverin as a cancer-retina antigen

    • Alexandr V. Bazhin
    • Dirk Schadendorf
    • Stefan B. Eichmüller

    Symposium Paper 28 January 2006 Pages: 110 - 116

    

13. Immunotherapy of renal cell carcinoma

    • Cécile Gouttefangeas
    • Arnulf Stenzl
    • Hans-Georg Rammensee

    Symposium Paper 05 May 2006 Pages: 117 - 128